0001415889-24-019339.txt : 20240708
0001415889-24-019339.hdr.sgml : 20240708
20240708161511
ACCESSION NUMBER: 0001415889-24-019339
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240703
FILED AS OF DATE: 20240708
DATE AS OF CHANGE: 20240708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brady Stephen R
CENTRAL INDEX KEY: 0001606241
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 241104886
MAIL ADDRESS:
STREET 1: C/O IMMUNE DESIGN CORP.
STREET 2: 1616 EASTLAKE AVE. E, SUITE 310
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tempest Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 415-798-8589
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: Millendo Therapeutics, Inc.
DATE OF NAME CHANGE: 20181207
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
4
1
form4-07082024_040701.xml
X0508
4
2024-07-03
0001544227
Tempest Therapeutics, Inc.
TPST
0001606241
Brady Stephen R
C/O TEMPEST THERAPEUTICS, INC.
2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE
CA
94005
true
true
false
false
President and CEO
0
Common Stock
2024-07-03
4
P
0
35000
2.11
A
46376
D
Includes 11,376 shares acquired under the Issuer's stock purchase plan.
/s/ Nicholas Maestas, Attorney-in-Fact
2024-07-08